Volume 126, Issue 4, Pages (April 2004)

Slides:



Advertisements
Similar presentations
Value in Health Regional Issues
Advertisements

Volume 60, Issue 2, Pages (February 2014)
Volume 139, Issue 2, Pages (August 2010)
Volume 50, Issue 4, Pages (April 2009)
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection  Yi–Cheng Chen, I.–Shyan Sheen,
A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection 
R. Cavallo  Clinical Microbiology and Infection 
Volume 148, Issue 7, Pages e3 (June 2015)
Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.
Volume 136, Issue 4, Pages (April 2009)
Volume 136, Issue 4, Pages (April 2009)
Volume 147, Issue 1, Pages (July 2014)
Volume 138, Issue 5, Pages e1 (May 2010)
Covering the Cover Gastroenterology
Volume 142, Issue 5, Pages e3 (May 2012)
Uchenna H. Iloeje, Hwai–I
Volume 139, Issue 2, Pages (August 2010)
Effectiveness of Hepatitis B Treatment in Clinical Practice
Level of Hepatitis B Virus DNA in Inactive Carriers With Persistently Normal Levels of Alanine Aminotransferase  Chia–Ming Chu, Yi–Cheng Chen, Dar–In.
Volume 153, Issue 4, Pages (October 2017)
Hepatitis B and C virus-related carcinogenesis
Value in Health Regional Issues
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
Volume 127, Issue 6, Pages (December 2004)
Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective.
Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection  Sahil Mittal, Jennifer R. Kramer, Ronald Omino,
Introduction The American Journal of Medicine
Volume 69, Issue 2, Pages (August 2018)
Identification of a Hepatitis B Virus S Gene Mutant in Lamivudine-Treated Patients Experiencing HBsAg Seroclearance  Chao-Wei Hsu, Chau-Ting Yeh, Ming-Ling.
Volume 133, Issue 5, Pages (November 2007)
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C  Chi–Jen Chu, Munira Hussain,
A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study  M.-C. Tsai,
Volume 154, Issue 4, Pages (March 2018)
Synergistic Effects of Family History of Hepatocellular Carcinoma and Hepatitis B Virus Infection on Risk for Incident Hepatocellular Carcinoma  Rohit.
Volume 133, Issue 5, Pages (November 2007)
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C  Miya John, Mayada Metwally  Gastroenterology 
Volume 155, Issue 5, Pages e2 (November 2018)
Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B  Yasuji Arase, MD, Kenji Ikeda, MD, Fumitaka Suzuki,
Volume 139, Issue 2, Pages (August 2010)
Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H
Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?  Brian J. McMahon, MD, Brenna C. Simons, PhD  Clinical.
Navigating the Maze of Hepatitis B Treatments
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Ming-Ling Chang, Yun-Fan Liaw  Journal of Hepatology 
Volume 142, Issue 6, Pages e3 (May 2012)
Validation of Hepascore, Compared With Simple Indices of Fibrosis, in Patients With Chronic Hepatitis C Virus Infection in United States  Laren Becker,
Volume 127, Issue 6, Pages (December 2004)
Volume 132, Issue 7, Pages (June 2007)
Hepatitis B and C virus-related carcinogenesis
Volume 150, Issue 7, Pages (June 2016)
Volume 50, Issue 4, Pages (April 2009)
Hepatitis B Virus Load in Serum Does Not Reflect Histologic Activity in Patients With Decompensated Cirrhosis  Jin Dong Kim, Jong Young Choi, Si Hyun.
Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg 
Volume 135, Issue 4, Pages (October 2008)
Ju Dong Yang, W. Ray Kim, Ritika Coelho, Teresa A. Mettler, Joanne T
Yun-Fan Liaw, Wen-Juei Jeng, Ming-Ling Chang  Gastroenterology 
Volume 125, Issue 6, Pages (December 2003)
Volume 151, Issue 3, Pages e1 (September 2016)
Jia-Horng Kao*, Pei-Jer Chen*, Ming-Yang Lai*, Ding-Shinn Chen‡,§ 
Volume 156, Issue 3, Pages (February 2019)
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection  Yi–Cheng Chen, I.–Shyan Sheen,
Hashem B. El-serag, Thomas Tran, James E. Everhart  Gastroenterology 
Covering the Cover Gastroenterology
Effects of Arsenic in Drinking Water on Risk of Hepatitis or Cirrhosis in Persons With and Without Chronic Viral Hepatitis  Ling-I. Hsu, Yuan-Hung Wang,
Volume 130, Issue 3, Pages (March 2006)
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma  Jin-de Chen, Chun-jen Liu, Po-huang Lee, Pei-jer.
Volume 115, Issue 4, Pages (October 1998)
Volume 156, Issue 4, Pages (March 2019)
Presentation transcript:

Volume 126, Issue 4, Pages 1024-1029 (April 2004) Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection  Yun-Fan Liaw, Yi-Cheng Chen, I-Shyan Sheen, Rong-Nan Chien, Chau-Ting Yeh, Chia-Ming Chu  Gastroenterology  Volume 126, Issue 4, Pages 1024-1029 (April 2004) DOI: 10.1053/j.gastro.2004.01.011

Figure 1 Comparison of the cumulative probability of hepatitis B surface antigen (HBsAg) clearance after the onset of acute hepatitis C virus (HCV) or delta virus (HDV) superinfection and patients with active chronic hepatitis B (HBV). Note that the difference is significant only when compared between the HCV and the HBV group within 10 years. The cumulative HBsAg clearance rate in the HDV group and the HBV group exceeds that of the HCV group after 16 years follow-up, but the numbers of patients were small. Gastroenterology 2004 126, 1024-1029DOI: (10.1053/j.gastro.2004.01.011)

Figure 2 The cumulative probability of cirrhosis development after the onset of acute hepatitis C virus (HCV) is significantly higher than that of matched patients with acute hepatitis delta virus (HDV) superinfection and a matched control group of active chronic hepatitis B (HBV). Gastroenterology 2004 126, 1024-1029DOI: (10.1053/j.gastro.2004.01.011)

Figure 3 The cumulative probability of hepatocellular carcinoma (HCC) development after the onset of acute hepatitis C virus (HCV) is higher than that of matched patients with acute hepatitis delta virus (HDV) superinfection at a marginally significant level but significantly higher than the matched control group of active chronic hepatitis B (HBV). Gastroenterology 2004 126, 1024-1029DOI: (10.1053/j.gastro.2004.01.011)